ArticleAnnals of Ibadan postgraduate medicine2024
THE PLASMA CONCENTRATIONS OF ESSENTIAL TRACE ELEMENTS IN WOMEN WITH CANCER OF BREAST- OR CERVIX.
Article in Annals of Ibadan postgraduate medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Derangement of trace elements which could be due to systemic inflammation or oxidative stress is thought to be directly or indirectly involved in carcinogenesis. Aim: To evaluate plasma trace elements in female patients with cancer of breast- or cervix. Material and Methods: This study was carried out in the Departments of Immunology and Radiation Oncology, University of Ibadan, Nigeria. Thirty (30) patients with cervical cancer, 30 patients with breast cancer and 30 age-matched females without cancer as control were included in the study. Plasma separated from venous blood was analysed for the concentrations of zinc (Zn), iron (Fe), selenium (Se) and copper (Cu) using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). The sixty cancer patients were newly diagnosed and in a stable state. Results: The mean plasma levels of Fe and Cu were significantly reduced in patients with breast cancer- or cervical cancer compared with control. The plasma concentrations of Fe, Cu, Zn and Se were significantly reduced in all patients having breast cancer and those in stage 2 compared with cervical cancer patients. Conclusion: Available data further support a previous suggestion that blood levels of metal varies with different cancers. Thus, a need for differential supplementation based on cancer types when modulation of trace element levels becomes a therapeutic option.
Indexed as
Identifiers
40385711PMC12082666What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.